GM

Gregory A. McClelland

Merck: 5 patents #2,116 of 9,382Top 25%
NB Neurocrine Biosciences: 4 patents #49 of 128Top 40%
AV Abb Vie: 2 patents #598 of 1,257Top 50%
Overall (All Time): #547,988 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12102637 Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis Jayanthy Jayanth, Kevin C. Spence, Anna V. Stepanenko, Tzuchi R. Ju, Xi Shao 2024-10-01
12083227 Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis Yihong Qiu, Yuchuan Gong, Alexander Ruggles, Jared A. Baird, Hui Zu +1 more 2024-09-10
11311532 High dosage valbenazine formulation and compositions, methods, and kits related thereto Richard A. Moore, Christopher O'Brien 2022-04-26
11026939 High dosage valbenazine formulation and compositions, methods, and kits related thereto Richard A. Moore, Christopher F. O{grave over ( )}Brien 2021-06-08
5350584 Spheronization process using charged resins Gaylen M. Zentner 1994-09-27
5120548 Swelling modulated polymeric drug delivery device Gaylen M. Zentner 1992-06-09
4994273 Solubility modulated drug delivery device Gaylen M. Zentner 1991-02-19
4976967 Resin modulated drug delivery device for the delivery of HMG-CoA reductase inhibitor salts Gaylen M. Zentner, Stefano A. Pogany 1990-12-11
4946686 Solubility modulated drug delivery system Gaylen M. Zentner 1990-08-07